Ramona Sequeira is President of Takeda’s US Business Unit and leads Takeda’s Portfolio Commercialization globally. She serves as a member of Takeda’s global Executive Team. Ramona joined Takeda in 2015. Through her work with Takeda and, prior to that, with Eli Lilly, she has more than 25 years of experience in the pharmaceutical industry. Having led businesses in Canada, Europe and the U.S., Ramona has worked across multiple markets, cultures and healthcare systems. She has successfully launched products, integrated and transformed businesses, and delivered sustainable growth, while driving high employee engagement and organizational alignment. Since joining Takeda, Ramona has shifted the structure of Takeda’s U.S. Business and altered the investment mix to enable focus, agility, and sustainable, patient centric growth. She has aligned her organization around a common vision, values and culture, areas which she believes are fundamental to long-term organizational success. In her role as President of Global Portfolio Commercialization, Ramona chairs Takeda’s New Product Commercialization Committee, overseeing and ensuring success of global product launches of Takeda’s pipeline assets. Ramona is a member of the PhRMA Board of Directors and was recently appointed Treasurer of the Board. Prior to that, she served as Chair of PhRMA’s State Committee. She is committed to the industry’s role in shaping a positive environment that rewards pharmaceutical innovation and ensures patients have access to life changing medicines. Ramona is also a member of the Board of Directors of Edwards Life Sciences, and the Board of Trustees of Harvey Mudd College. Ramona received a Master of Business Administration degree from McMaster University in Canada and has a Bachelor of Science degree with Honors in Molecular Genetics and Molecular Biology from the University of Toronto. She resides with her family in the Boston area.